Citation: Cs. Miller et Bm. Johnstone, Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997, ORAL SURG O, 91(6), 2001, pp. 622-635
Authors:
Edgell, ET
Andersen, SW
Johnstone, BM
Dulisse, B
Revicki, D
Breier, A
Citation: Et. Edgell et al., Olanzapine versus risperidone - A prospective comparison of clinical and economic outcomes in schizophrenia, PHARMACOECO, 18(6), 2000, pp. 567-579
Citation: Sl. Tunis et al., Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia, J CLIN PSY, 60, 1999, pp. 38-45
Citation: Sl. Tunis et al., Reliability, validity, and application of the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol, MED CARE, 37(7), 1999, pp. 678-691
Authors:
Williams, CL
Johnstone, BM
Kesterson, JG
Javor, KA
Schmetzer, AD
Citation: Cl. Williams et al., Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia, MED CARE, 37(4), 1999, pp. AS81-AS86